7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                 
      cash flows from operating activities:
    		                 
      net income
    		-110,207,000 -104,370,000 12,112,000 -105,790,000 -117,615,000 -30,662,000 -6,034,000 -230,484,000 15,959,000 -56,549,000 -30,739,000 -20,731,000 1,155,000 -56,737,000 -35,958,000 -298,941,000 -15,151,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      depreciation and amortization
    		7,430,000 7,319,000 6,876,000 6,494,000 6,218,000 5,907,000 5,844,000 5,147,000 4,189,000 3,907,000 3,450,000 3,042,000 3,373,000 3,638,000 3,937,000 3,614,000 3,481,000 
      stock-based compensation expense
    		7,498,000 15,381,000 16,720,000 2,282,000 13,259,000 18,207,000 16,909,000 15,515,000 13,672,000 9,951,000 7,907,000 6,553,000 3,970,000 4,414,000 11,960,000 274,548,000 1,472,000 
      loss (income) from equity method investments
    		-13,133,000 -5,412,000 -12,672,000 2,694,000 -2,047,000 -9,955,000 -5,684,000 8,018,000 -1,376,000 -7,247,000 4,314,000 -5,754,000 -2,033,000 8,846,000 452,000   
      distributions of earnings from equity method investments
    		   0 0             
      adjustments on sale of assets
    		0 0 -14,000,000               
      other noncash items
    		-2,464,000 -878,000 -2,229,000  346,000 -365,000 -472,000  -1,785,000  764,000 2,941,000 556,000  -2,122,000 245,000 1,766,000 
      changes in operating assets and liabilities:
    		  -38,794,000  92,136,000 -3,977,000 -63,335,000           
      net cash from operating activities
    		-18,154,000 -35,085,000 -31,987,000 16,419,000 -7,703,000 -18,717,000 -47,776,000 -61,166,000 -60,811,000 -49,959,000 2,647,000 -60,263,000 -23,233,000 -48,897,000 -19,143,000 -39,291,000 -40,828,000 
      capex
    		-3,175,000 -3,250,000 -3,849,000 -3,266,000 -3,534,000 -3,312,000 -3,139,000 -3,932,000 -3,717,000 -3,489,000 -3,433,000 -4,455,000 -4,049,000 -3,400,000 -2,518,000 -468,000 -178,000 
      free cash flows
    		-21,329,000 -38,335,000 -35,836,000 13,153,000 -11,237,000 -22,029,000 -50,915,000 -65,098,000 -64,528,000 -53,448,000 -786,000 -64,718,000 -27,282,000 -52,297,000 -21,661,000 -39,759,000 -41,006,000 
      cash flows from investing activities:
    		                 
      purchase of property and equipment
    		-3,175,000 -3,250,000 -3,849,000 -3,266,000 -3,534,000 -3,312,000 -3,139,000 -3,932,000 -3,717,000 -3,489,000 -3,433,000 -4,455,000 -4,049,000 -3,400,000 -2,518,000 -468,000 -178,000 
      purchase of intangible assets
    		-13,359,000 -2,683,000 -7,034,000 -9,157,000 -984,000 -6,455,000 -11,438,000 -11,450,000  -4,820,000 -247,000 -11,168,000 -1,000,000 -68,000 -2,776,000 -32,000 -3,986,000 
      investment in loans receivable and other
    		0    0    -1,301,000  0 -7,000 -4,503,000  -6,306,000 -69,103,000 -1,204,000 
      investments in marketable securities
    		0 -12,637,000 -47,517,000 0 0   -7,637,000 -29,969,000 -35,082,000 -138,106,000       
      proceeds from maturities of marketable securities and other
    		35,192,000 90,028,000 35,311,000  51,081,000 41,224,000 74,523,000           
      net cash from investing activities
    		18,658,000 70,458,000 -23,089,000 23,673,000 46,563,000 18,217,000 51,438,000 -2,203,000 -50,814,000 -7,970,000 -130,938,000 -296,611,000 -8,869,000 -2,603,000 -11,565,000 -67,264,000 -9,074,000 
      cash flows from financing activities:
    		                 
      proceeds from (payments for) equity issuances
    		-236,000                 
      repayments of long-term debt
    		   0 -1,250,000 -1,250,000 -1,250,000  -1,250,000  -1,250,000 -1,250,000 -1,250,000     
      net cash from financing activities
    		-236,000 -2,580,000 -161,000 -22,000 -1,406,000 -1,714,000 559,000 -845,000 8,339,000 1,130,000 9,111,000 4,309,000 13,506,000 10,417,000 896,000 1,112,779,000 30,298,000 
      net increase in cash, cash equivalents and restricted cash and equivalents
    		268,000 32,793,000 -55,237,000 40,070,000 37,454,000 -2,214,000 4,221,000 -64,214,000 -103,286,000 -56,799,000 -119,180,000 -352,565,000 -18,596,000 -41,083,000 -29,812,000 1,006,224,000 -19,604,000 
      cash, cash equivalents and restricted cash and equivalents, beginning of period
    		0 0 193,860,000  0 0 114,329,000  507,680,000  0 0 1,054,820,000  0 0 139,095,000 
      cash, cash equivalents and restricted cash and equivalents, end of period
    		268,000 32,793,000 138,623,000  37,454,000 -2,214,000 118,550,000  404,394,000  -119,180,000 -352,565,000 1,036,224,000  -29,812,000 1,006,224,000 119,491,000 
      changes in operating assets and liabilities
    		        -91,470,000  16,951,000 -46,314,000 -30,254,000  2,588,000 -16,629,000 -33,582,000 
      proceeds from equity issuances
    		  -161,000 -22,000 -156,000 -464,000 1,809,000  9,589,000         
      impairments
    		                 
      deferred income taxes and uncertain tax positions
    		                 
      release of indemnification assets
    		                 
      (gain) loss on sale of assets
    		   0   4,996,000           
      other non-cash items
    		                 
      receivables
    		                 
      prepaid expense and other current assets
    		                 
      other assets
    		                 
      medical claims and related payables
    		                 
      accounts payable and accrued expenses
    		                 
      other liabilities
    		                 
      investments in loans receivable and other
    		                 
      proceeds from maturities and sales of marketable securities and other
    		       30,146,000 28,540,000         
      net cash paid in business combination
    		       -773,000 -44,367,000         
      proceeds from sale of business and property, net of cash divested
    		         0 0 0 500,000 1,300,000 0   
      common stock repurchase
    		       0          
      cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year
    		                 
      cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year
    		                 
      cash, cash equivalents and restricted cash and equivalents, beginning of year
    		                 
      cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year
    		                 
      cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year
    		                 
      cash, cash equivalents and restricted cash and equivalents, end of year
    		                 
      cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period
    		    0 0 114,329,000    0 0 1,054,820,000  0 0 135,178,000 
      cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period
    		              0 0 3,917,000 
      cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period
    		    37,454,000 -2,214,000 118,550,000        -29,812,000 1,006,224,000 119,491,000 
      cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period
    		                 
      (gain) loss on sale of assets, net and impairments
    		                 
      funding of loans receivable and other
    		      -8,508,000           
      loss on debt extinguishment
    		             0 0 404,000 1,186,000 
      proceeds from initial public offering
    		             0 0   
      proceeds from other equity issuances
    		         2,380,000 10,361,000       
      proceeds from the issuance of long-term debt
    		             0 0 0 100,000,000 
      repayments of long-term borrowings and other
    		             -1,252,000 1,000   
      equity and debt issuance costs and other
    		             -4,811,000 -160,000   
      repurchase of shares
    		                 
      proceeds from sale of marketable securities and other
    		                 
      proceeds from repayment of loans receivable and other
    		           4,096,000 183,000     
      proceeds from exercise of stock options
    		            14,756,000 16,480,000 1,055,000 386,000 165,000 
      debt issuance costs
    		                -1,218,000 
      distribution to noncontrolling interests
    		                 
      computer equipment and software
    		                 
      furniture and fixtures
    		                 
      building
    		                 
      proceeds from repayment of loans receivable
    		              35,000   
      proceeds from sale of business, net of cash divested
    		                -3,706,000 
      repayments of long-term borrowings
    		                -68,649,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.